Literature DB >> 8087847

Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein.

R Fagan1, K J Flint, N Jones.   

Abstract

The transcription factor E2F is regulated through its cyclical interaction with a spectrum of cellular proteins. One such protein is the product of the retinoblastoma gene (Rb); association of E2F with Rb inhibits its transactivation potential. However, in adenovirus-infected cells, E2F is complexed to the 19 kDa product of the adenovirus E4 gene. We have studied the interaction of E2F-1 with the Rb and adenovirus E4 proteins and show that phosphorylation of E2F-1 on serine residues 332 and 337 prevented its interaction with Rb but was a prerequisite for interaction with E4. These residues were phosphorylated in vivo and by p34cdc2 kinase in vitro. Upon stimulation of serum-starved cells, phosphorylation was induced in the late G1 phase of the cell cycle. These observations suggest that phosphorylation of E2F-1 is important in the regulation of its activity during the cell cycle and during infection of cells by adenovirus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087847     DOI: 10.1016/s0092-8674(94)90522-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  39 in total

1.  Distinct cellular factors regulate the c-myb promoter through its E2F element.

Authors:  M R Campanero; M Armstrong; E Flemington
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 2.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

3.  Protein-protein interaction panel using mouse full-length cDNAs.

Authors:  H Suzuki; Y Fukunishi; I Kagawa; R Saito; H Oda; T Endo; S Kondo; H Bono; Y Okazaki; Y Hayashizaki
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

4.  Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants.

Authors:  D Sitterlin; T H Lee; S Prigent; P Tiollais; J S Butel; C Transy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Concurrent quantification of proteome and phosphoproteome to reveal system-wide association of protein phosphorylation and gene expression.

Authors:  Yi-Bo Wu; Jie Dai; Xing-Lin Yang; Su-Jun Li; Shi-Lin Zhao; Quan-Hu Sheng; Jia-Shu Tang; Guang-Yong Zheng; Yi-Xue Li; Jia-Rui Wu; Rong Zeng
Journal:  Mol Cell Proteomics       Date:  2009-08-12       Impact factor: 5.911

6.  Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.

Authors:  P D Adams; X Li; W R Sellers; K B Baker; X Leng; J W Harper; Y Taya; W G Kaelin
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

7.  Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.

Authors:  S de la Luna; K E Allen; S L Mason; N B La Thangue
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

8.  The differential binding of E2F and CDF repressor complexes contributes to the timing of cell cycle-regulated transcription.

Authors:  F C Lucibello; N Liu; J Zwicker; C Gross; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

9.  Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins.

Authors:  S Pajovic; E L Wong; A R Black; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

10.  Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1.

Authors:  J A Bogdan; C Adams-Burton; D L Pedicord; D A Sukovich; P A Benfield; M H Corjay; J K Stoltenborg; I B Dicker
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.